Sökresultat

Filtyp

Din sökning på "*" gav 134459 sökträffar

Biomarkers reveal risk of cardiovascular disease in type 2 diabetes

An international research team led from Lund University, has identified epigenetic biomarkers that can predict which people with type 2 diabetes are at risk of cardiovascular disease. The study is now published in Cell Reports Medicine. People with type 2 diabetes are up to four times more likely to have heart attacks, strokes, anginas and other coronary heart diseases than healthy people. Therefo

https://www.ludc.lu.se/article/biomarkers-reveal-risk-cardiovascular-disease-type-2-diabetes - 2026-04-17

Award for protein research that may lead to new treatments of diabetes

Inflammation researcher Ben King studies the function of two different proteins in connection with diabetes. In the future, such knowledge may be important for the development of new treatments for people with diabetes. Ben King is this year’s recipient of the Medeon Award for his innovative research. “I was very surprised and feel very honored to receive the award. In my role, I do a lot of exper

https://www.ludc.lu.se/article/award-protein-research-may-lead-new-treatments-diabetes - 2026-04-17

Six LUDC researchers receive medicine and health grants from VR

We would like to congratulate six researchers at Lund University Diabetes Centre, who have been awarded research grants within medicine and health by the Swedish Research Council (VR). The six researchers are affiliated with Excellence of Diabetes Research in Sweden (EXODIAB), which is a strategic research area within diabetes at Lund University.Helena Elding Larsson, professor of autoimmune disea

https://www.ludc.lu.se/article/six-ludc-researchers-receive-medicine-and-health-grants-vr - 2026-04-17

Oral insulin delayed onset of type 1 diabetes in some children with increased risk of the disease

An international team of researchers has investigated whether oral insulin can prevent early signs of type 1 diabetes and clinical diagnosis in children with an increased risk of developing the disease. Although treatment with oral insulin could not prevent development of diabetes-related autoantibodies, oral insulin delayed the rate of disease progression in children who developed such autoantibo

https://www.ludc.lu.se/article/oral-insulin-delayed-onset-type-1-diabetes-some-children-increased-risk-disease - 2026-04-17

Review: Type 2 diabetes and obesity – what do we really know?

This article is over 5 years old, and the information may therefore be outdated. Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world. In a review in Science, Mark McCarthy, professor at the University of Oxford, UK, and Paul Franks, professor at Lund University, Sweden, examine the knowledge of the actual causes and the interplay between genetics

https://www.ludc.lu.se/article/review-type-2-diabetes-and-obesity-what-do-we-really-know - 2026-04-17

New research on classification of diabetes identifies high-risk group

Diabetes researchers at Lund University have previously shown that people with diabetes can be stratified into five subgroups with differing disease progression. A new study by the same researchers provides increased evidence for the clinical relevance of the classification system. The researchers also present new findings of significant differences between subgroups in the development of complica

https://www.ludc.lu.se/article/new-research-classification-diabetes-identifies-high-risk-group - 2026-04-17

Stem cell technology reveals new insights into melatonin and diabetes

How can a tiny genetic change alter the body´s sugar balance? At Lund University, researchers have used stem cells to create two versions of the same cell – one carrying the genetic variant and one without – to see how melatonin affects insulin-producing cells and contributes to development of type 2 diabetes. Study summarySkin cells from a person carrying a risk gene for type 2 diabetes were “rep

https://www.ludc.lu.se/article/stem-cell-technology-reveals-new-insights-melatonin-and-diabetes - 2026-04-17

Hope for kidney care

DIABETES. After more than a decade of stagnation, there is a major surge in kidney research effort. New drugs and biomarkers make it possible to detect and slow the progression of the disease earlier – something that long seemed unattainable. This will impact people with diabetes, for whom kidney damage is a serious long-term complication. “We are entering a new era. What is happening now is simil

https://www.ludc.lu.se/article/hope-kidney-care - 2026-04-17

Precision medicine research within type 2 diabetes and dementia receives support

Three research groups at Lund University Diabetes Centre receive new project grants within precision medicine. The aim with the projects is to develop individualised treatment strategies that may benefit people with type 2 diabetes. One of the new projects will investigate whether it is possible to develop individualised treatment strategies for people with type 2 diabetes. The project EPIPREDIA i

https://www.ludc.lu.se/article/precision-medicine-research-within-type-2-diabetes-and-dementia-receives-support - 2026-04-17

Capturing the moment a cell shuts the door on free radicals

For the first time, researchers have been able to show how a cell closes the door to free radicals – small oxygen molecules that are sometimes needed, but that can also damage our cells. The study is published in Nature Communications and was led from Lund University. For our cells to function, they need to maintain a careful balance between beneficial and harmful oxygen molecules known as free ra

https://www.ludc.lu.se/article/capturing-moment-cell-shuts-door-free-radicals - 2026-04-17

Laura Elo is awarded the Leif C. Groop Award for outstanding research on type 1 diabetes

Laura Elo at University of Turku is awarded the Leif C. Groop Award for outstanding research on type 1 diabetes. The mathematician from Finland has developed methods which have helped increase the understanding of how type 1 diabetes develops at molecular level. She hopes her research will help prevent and delay the progression of the disease and individualise the treatment of type 1 diabetes. Jus

https://www.ludc.lu.se/article/laura-elo-awarded-leif-c-groop-award-outstanding-research-type-1-diabetes - 2026-04-17

New research identifies potential treatment target in fatty liver disease

Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause more serious liver conditions, such as liver failure. A new study, led by Lund University in Sweden, presents new data that may lead to better disease management and prevention of in the future. The international research team identified an altered expression of specific genes in samples from individuals with obesity, MASLD

https://www.ludc.lu.se/article/new-research-identifies-potential-treatment-target-fatty-liver-disease - 2026-04-17

A genetic brake that forms our muscles

In an international study, researchers at Lund University in Sweden have identified a gene variant that controls the body’s capability to form new blood vessels in muscles – a mechanism that affects physical performance, health and recovery. The favourable gene variant is considerably more common among top athletes in endurance sports, compared with both top athletes in explosive sports and non-at

https://www.ludc.lu.se/article/genetic-brake-forms-our-muscles - 2026-04-17

Mapping of gene variants which affect gut microbiota and disease risk

Studies of the gut microbiota can provide new knowledge about human health and how the risk of developing various diseases is affected. Marju Orho-Melander at Lund University is one of the authors of two new articles in Nature Genetics which have discovered several new gene variants in the human genome which may influence which bacteria are found in the gut. Some of the new gene variants can be li

https://www.ludc.lu.se/article/mapping-gene-variants-which-affect-gut-microbiota-and-disease-risk - 2026-04-17

Lund initiates genetic sequencing study in diabetes families to provide new insights into what causes the disease

This article is over 5 years old, and the information may therefore be outdated. Lund University Diabetes Centre has entered into a collaboration with the Regeneron Genetics Center LLC (RGC) and the University of Helsinki involving exome-sequencing and whole genome array genotyping of greater than 9,000 individuals. The collaboration will involve the largest sequencing study in diabetes families t

https://www.ludc.lu.se/article/lund-initiates-genetic-sequencing-study-diabetes-families-provide-new-insights-what-causes-disease - 2026-04-17

Antibiotics can have long-term effect on gut microbiota

Antibiotic treatments help the body to fight infections and should have as little negative impact on humans as possible. A new study in the journal Nature Medicine shows that the use of antibiotics can affect the human gut microbiota for several years. The study found that some types of antibiotics had a greater impact on the gut microbiota than others. “It is great that we have antibiotics which

https://www.ludc.lu.se/article/antibiotics-can-have-long-term-effect-gut-microbiota - 2026-04-17

THADA - new findings in the role of the mother in type 2 diabetes

This article is over 5 years old, and the information may therefore be outdated. Research from Lund University in Sweden can explain why type 2 diabetes is inherited to a greater extent from an individual’s mother. The heredity of a previously known risk gene, THADA, has proven to be dominant if it comes from the mother, whereas it has little or no effect on the child’s risk of disease if it origi

https://www.ludc.lu.se/article/thada-new-findings-role-mother-type-2-diabetes - 2026-04-17

Climate-friendly diet yielded unexpectedly strong nutritional outcomes

That eating plenty of vegetables, wholegrains and legumes is beneficial for health is well known. More surprising, however, is that people who eat in a environmentally-friendly way also display nutritional values that are better than researchers had expected. This is shown in a new study from Lund University. The EAT–Lancet diet is a global dietary guideline developed to promote both human health

https://www.ludc.lu.se/article/climate-friendly-diet-yielded-unexpectedly-strong-nutritional-outcomes - 2026-04-17

Researchers predict coronary heart disease in diabetes subgroup

A growing body of research shows that diabetes can be stratified into five different subgroups. Researchers at Lund University have now investigated whether a person’s genetic predisposition to different diabetes subgroups can help assess the risk of developing coronary artery disease. The team created genetic risk scores and found that the scores for one subgroup could predict coronary artery dis

https://www.ludc.lu.se/article/researchers-predict-coronary-heart-disease-diabetes-subgroup - 2026-04-17

New findings explain the connection between melatonin and type 2 diabetes

This article is over 5 years old, and the information may therefore be outdated. A new experimental and clinical study from Lund University in Sweden shows that the sleep hormone melatonin impairs insulin secretion in people with a common gene variant.

“This could explain why the risk of type 2 diabetes is greater among, for instance, overnight workers or people with sleeping disorders”, says Pro

https://www.ludc.lu.se/article/new-findings-explain-connection-between-melatonin-and-type-2-diabetes - 2026-04-17